[1]赵迪,徐佳.中医药抗肝纤维化疗效评价的探索[J].西部中医药,2023,36(04):150-153.[doi:10.12174/j.issn.2096-9600.2023.04.35]
　ZHAO Di,Xu jia.Exploration on the Evaluation of Therapeutic Effects of TCM on Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(04):150-153.[doi:10.12174/j.issn.2096-9600.2023.04.35]
点击复制

中医药抗肝纤维化疗效评价的探索
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年04期
页码:
150-153
栏目:
出版日期:
2023-04-15

文章信息/Info

Title:
Exploration on the Evaluation of Therapeutic Effects of TCM on Liver Fibrosis
作者:
赵迪1, 徐佳2
1.北京中医药大学，北京 100029
2.北京中医药大学第三附属医院，北京 100029
Author(s):
ZHAO Di1, Xu jia2
1.Beijing University of Traditional Chinese Medicine, Beijing 100029, China
2.Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China
关键词:
肝纤维化; 中医药; 临床疗效; 评价方法
Keywords:
liver fibrosis; TCM; clinical effects; evaluation method
分类号:
R657.3+1
DOI:
10.12174/j.issn.2096-9600.2023.04.35
文献标志码:
A
摘要:
通过大量实验探索研究，中成药与有效经验方在治疗肝纤维化方面疗效明显，并初步形成了中西医结合抗肝纤维化治疗方案，但中医临床疗效评价尚未形成准确统一的评价方法，文章通过数学模型与循证医学方面探讨如何建立行之有效的中医药治疗肝纤维化的评价指标。
Abstract:
Through a large number of experimental exploration and research, Chinese patent medicine and the effective empirical formula are effective in the treatment of liver fibrosis, and initially form anti-liver fibrosis treatment program with integrated Chinese and Western medicine, however, an accurate and unified evaluation method has not been found in the evaluation of TCM clinical effects, the paper explores how to establish the effective evaluation indexes of the treatment of liver fibrosis through mathematical model and evidence-based medicine.

相似文献/References:

[1]蔺彩娟,甘欣锦△.自拟三子补血汤 治疗化疗后骨髓抑制的经验[J].西部中医药,2012,25(10):47.
　LIN Cai-juan,GAN Xin-jin.Experience on Treating Arrest of Bone Marrow after Chemotherapy with Self-made SanZi BuXueTang[J].Western Journal of Traditional Chinese Medicine,2012,25(04):47.
[2]聂静怡,应森林.周边国家和地区中医药国际教育需求分析[J].西部中医药,2013,26(01):48.
　NIE Jingyi,YING Senlin.Analysis on the Demand of TCM International Education in the Districts and Its Neighboring Countries[J].Western Journal of Traditional Chinese Medicine,2013,26(04):48.
[3]舒劲,杨宏武.中医药在突发公共卫生事件中的应用与探讨[J].西部中医药,2013,26(01):59.
　SHU Jin,YANG Hongwu.Exploration and Application of TCM in the Public Health Emergencies[J].Western Journal of Traditional Chinese Medicine,2013,26(04):59.
[4]鲁培俊,文建强,王冠华,等.兰州市社区卫生服务机构中医药健康教育资源现状调查分析[J].西部中医药,2013,26(01):72.
　LU Peijun,WEN Jianqiang,WANG Guanhua,et al.Investigation on Current State of TCM Health Education Resources in Lanzhou Community Health Service Institutes[J].Western Journal of Traditional Chinese Medicine,2013,26(04):72.
[5]张海清,赵继荣△,陈文.腰椎间盘突出症的中医药治疗概述[J].西部中医药,2012,25(12):124.
　ZHANG Hai-qing,ZHAO Ji-rong,CHEN Wen.On TCM Therapy for Lumbar Intervertebral Disc Protrusion[J].Western Journal of Traditional Chinese Medicine,2012,25(04):124.
[6]李步满,卢世秀.中医药治疗更年期综合征的思路与方法[J].西部中医药,2013,26(11):44.
　LI Buman,LU Shixiu.Thinking and Method of TCM Therapy for Climacteric Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(04):44.
[7]郑辉,邓灵芝,张侬△,等.敦煌《灸经图》之“手小指头” “足小指头” “手十指头”穴[J].西部中医药,2012,25(08):51.
　ZHENG Hui,DENG Ling-zhi,ZHANG Nong,et al.Shou XiaoZhiTou, Zu XiaoZhiTou and ShouShiZhiTou Acupoints in JiuJingTu of Dunhuang[J].Western Journal of Traditional Chinese Medicine,2012,25(04):51.
[8]于立友,汪龙德△,张晶,等.化纤保肝方治疗气滞血瘀型肝纤维化的临床研究*[J].西部中医药,2013,26(10):84.
　YU Liyou,WANG Longde,ZHANG Jing,et al.Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):84.
[9]李双霞,张凤琴,李 娜.中医药在腹部术后胃肠功能恢复中的应用[J].西部中医药,2013,26(08):127.
　LI Shuangxia,ZHANG Fengqin,LI Na.Application of TCM to the Recovery of Gastrointestinal Function of the Patients Undergoing Abdominal Surgery[J].Western Journal of Traditional Chinese Medicine,2013,26(04):127.
[10]孙大伟,王凡,许国,等.体质干预治疗2型糖尿病前期患者33例[J].西部中医药,2014,27(01):104.
　SUN Dawei,WANG Fan,XU Guo,et al.Clinical Observation on Constitution Intervention in the Treatment for 33 Patients with Prediabetes of Type 2[J].Western Journal of Traditional Chinese Medicine,2014,27(04):104.
[11]张玉玲,闫雪华△,谢青.中药联合抗病毒药物治疗HBV所致肝纤维化的研究进展[J].西部中医药,2019,32(06):149.
　ZHANG Yuling,YAN Xuehua,XIE Qing.The Progress of Herbs Joined with Antiviral Drugs in the Treatment for HBV - induced Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(04):149.
[12]陈彩凤,胡振斌,黄家程,等.活血化瘀法治疗肝纤维化的研究进展[J].西部中医药,2022,35(12):166.[doi:10.12174/j.issn.2096-9600.2022.12.39]
　CHEN Caifeng,HU Zhenbin,HUANG Jiacheng,et al.Advances in Blood-activating Stasis-resolving Method in the Treatment of Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(04):166.[doi:10.12174/j.issn.2096-9600.2022.12.39]
[13]李瑛,胡振斌,张旭,等.中医药治疗肝纤维化研究概况[J].西部中医药,2023,36(07):138.[doi:10.12174/j.issn.2096-9600.2023.07.34]
　LI Ying,HU Zhenbin,ZHANG Xu,et al.Research Overview of TCM Treatment of Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(04):138.[doi:10.12174/j.issn.2096-9600.2023.07.34]

备注/Memo

备注/Memo:
赵迪（1997—），女，在读硕士研究生。研究方向：中西医结合外科。△；徐佳（1976—），男，博士学位，硕士研究生导师，主任医师。研究方向：肝胆外科疾病的中西医结合诊治及研究。
更新日期/Last Update: 2023-04-15